Pizzie Nick — SEC Form 4 filings
SEC reporting owner CIK 1742143. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-09.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-29 to 2026-06-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 3 filings — 60,000 shares, $12,129,540 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 33,000 shares @ $240.09 ($7,922,970) in Axsome Therapeutics, Inc., filed 2026-06-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | Chief Financial Officer | 7 | — | 4 legs · 60,000 sh · $12,129,540 | 15 |
Form 4 filings — Pizzie Nick
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-09 | 4 | Axsome Therapeutics, Inc. (AXSM) | Option exercise (M): 33,000 @ $3.50 · Sale (S): 33,000 @ $240.09 · Option exercise (M): 33,000 (derivative) @ $0 | EDGAR |
| 2026-04-23 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 8,188 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 18,570 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Axsome Therapeutics, Inc. (AXSM) | Option exercise (M): 12,000 @ $3.50 · Sale (S): 12,000 @ $187.92 · Option exercise (M): 12,000 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 9,516 (derivative) @ $0 · Grant/award (A): 9,423 (derivative) @ $0 · Grant/award (A): 9,423 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | Axsome Therapeutics, Inc. (AXSM) | Option exercise (M): 12,000 @ $3.50 · Sale (S): 12,000 @ $129.86 · Option exercise (M): 3,000 @ $3.50 · Sale (S): 3,000 @ $131.07 · Option exercise (M): 12,000 (derivative) @ $3.50 · Option exercise (M): 3,000 (derivative) @ $3.50 | EDGAR |
| 2024-02-29 | 4 | Axsome Therapeutics, Inc. (AXSM) | Grant/award (A): 28,722 (derivative) @ $0 · Grant/award (A): 15,774 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1742143 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →